Acorda Therapeutics Inc
NASDAQ:ACOR

Watchlist Manager
Acorda Therapeutics Inc Logo
Acorda Therapeutics Inc
NASDAQ:ACOR
Watchlist
Price: 0.65 USD -26.05% Market Closed
Updated: May 20, 2024

Acorda Therapeutics Inc
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Acorda Therapeutics Inc
Other Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Acorda Therapeutics Inc
NASDAQ:ACOR
Other Operating Expenses
$4.5m
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Operating Expenses
$169m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Other Operating Expenses
-$791m
CAGR 3-Years
-52%
CAGR 5-Years
-20%
CAGR 10-Years
-7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Operating Expenses
$49.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Operating Expenses
-$13.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Acorda Therapeutics Inc's Other Operating Expenses?
Other Operating Expenses
4.5m USD

Based on the financial report for Dec 31, 2023, Acorda Therapeutics Inc's Other Operating Expenses amounts to 4.5m USD.

What is Acorda Therapeutics Inc's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
-55%

Over the last year, the Other Operating Expenses growth was -67%. The average annual Other Operating Expenses growth rates for Acorda Therapeutics Inc have been -55% over the past three years .